Chwilio Deddfwriaeth

The Veterinary Medicines Regulations 2013

 Help about what version

Pa Fersiwn

 Help about advanced features

Nodweddion Uwch

Changes over time for: PART 3

 Help about opening options

Changes to legislation:

There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2013, PART 3. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

PART 3U.K.Fees payable by manufacturers

Application for a manufacturing authorisationE+W+S

28.[F1(1)] The fee for an application for a manufacturing authorisation for a veterinary medicinal product [F2is £762]

[F3(2) Fees relating to an application for a manufacturing authorisation are payable with the application.]

Application for a manufacturing authorisationN.I.

28.  The fee for an application for a manufacturing authorisation for a veterinary medicinal product is—

(a)£3,040; or

(b)£530 if the authorisation only covers veterinary medicinal products manufactured under Schedule 6 (exemptions for small pet animals).

Application for a variation of a manufacturing authorisationE+W+S

29.  The fee for an application for the variation of a manufacturing authorisation is—

(a)[F4£684] if the variation requires scientific or pharmaceutical assessment;

[F5(b)£105 if the variation only involves an administrative variation such as a change of ownership.”;]

F6(c). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F7(d). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Extent Information

E1This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Application for a variation of a manufacturing authorisationN.I.

29.  The fee for an application for the variation of a manufacturing authorisation is—

(a)£636 if the variation requires scientific or pharmaceutical assessment;

(b)£443 if the variation only involves a change of ownership;

(c)£210 if the authorisation only covers veterinary medicinal products manufactured under Schedule 6 (exemptions for small pet animals); and

(d)otherwise £350.

Extent Information

E10This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

[F8Inspection of sites authorised to manufacture a product for administration under the cascade]E+W+S

30.F9(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

[F10(2) The fees for the inspection of sites in connection with an authorisation (or an application for authorisation) for the manufacture of unauthorised veterinary medicinal products for administration under the cascade are set out in the following table—

Inspection fees
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site21,41622,710
Major site12,85014,144
Standard site6,4257,719
Minor site4,2835,577]

F11(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F12(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Extent Information

E2This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Application for an authorisation to manufacture an autogenous vaccine or a product for administration under the cascadeN.I.

30.—(1) The fee for an application for a standard authorisation to manufacture an autogenous vaccine or a veterinary medicinal product for administration under the cascade is—

(a)£3,435 for a site in the United Kingdom;

(b)£3,270 for a site outside the United Kingdom.

(2) The fee for each inspection after a standard authorisation has been granted is (in each case) the same as the fee specified in paragraph (1).

(3) In the case of an application for an individual authorisation to manufacture a single batch of autogenous vaccine, or a single batch of veterinary medicinal product for administration under the cascade the fee is £1,635.

(4) The fee to vary an authorisation is £305 if no further inspection is required, and otherwise is the full application fee.

Extent Information

E11This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

[F13Autogenous vaccinesE+W+S

30A.(1) The fee for the scientific assessment of an authorisation (or an application for authorisation) to manufacture an autogenous vaccine is £6,962.

(2) The fees for the inspection of sites in connection with an authorisation (or an application for authorisation) to manufacture autogenous vaccines are set out in the following table—]

Inspection fees
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site21,41622,710
Major site12,85014,144
Standard site6,4257,719
Minor site4,2835,577

[F13Assessment of a variation of an authorisation to manufacture an autogenous vaccineE+W+S

30B.  The fee for the scientific assessment of an application for the variation of an authorisation to manufacture an autogenous vaccine is—

(a)£2,895 if the variation requires complex scientific or pharmaceutical assessment;

(b)£885 if the variation requires simple scientific or pharmaceutical assessment;

(c)£455 in relation to an administrative variation.]

[F14Annual fee (manufacturing authorisations)E+W+S

31.  An annual fee of £575 is payable in respect of each manufacturing authorisation held.]

Extent Information

E3This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Annual feesN.I.

31.—(1) An annual fee of £550 is payable in respect of each manufacturing authorisation held (other than as specified in this paragraph).

(2) The annual fee for a manufacturing authorisation for an autogenous vaccine or a veterinary medicinal product for administration under the cascade is 0.67% of the turnover in the previous calendar year rounded to the next £1, with a minimum fee of £10.

(3) There is no annual fee for a manufacturing authorisation for a veterinary medicinal product manufactured in accordance with Schedule 6 for small pet animals.

(4) In this paragraph “turnover” means the sales value at manufacturers’ prices net of value added tax of all authorised veterinary medicinal products sold or supplied in the United Kingdom.

Extent Information

E12This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Site inspections – type of siteU.K.

32.  For the purposes of deciding the fee for a site inspection—

“super site” is a site at which 250 or more relevant persons are employed;

“major site” is a site at which 60 or more, but fewer than 250, relevant persons are employed;

“standard site” is a site at which 10 or more, but fewer than 60 relevant persons are employed;

“minor site” is a site at which fewer than 10 relevant persons are employed;

“relevant person” means a person employed on the premises and systems inspected.

Inspection of a site where immunological veterinary medicinal products are manufacturedE+W+S

33.  The fees for the inspection of a site where immunological veterinary medicinal products are manufactured are in accordance with the following table.

[F15Sites where immunological veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site32,12433,418
Major site21,41622,710
Standard site10,70812,002
Minor site6,4257,719]

Extent Information

E4This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Inspection of a site where immunological veterinary medicinal products are manufacturedN.I.

33.  The fees for the inspection of a site where immunological veterinary medicinal products are manufactured are in accordance with the following table.

Sites where immunological veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside United Kingdom
Super site24,07122,867
Major site16,78515,946
Standard site6,6616,327
Minor site4,7574,519

Extent Information

E13This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Inspection of a site where sterile veterinary medicinal products are manufacturedE+W+S

34.  The following fees are payable for the inspection of a site where no immunological veterinary medicinal products are manufactured, but where sterile products are manufactured.

[F16Sites where sterile veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site27,84129,135
Major site19,27420,569
Standard site10,70812,002
Minor site6,4257,719]

Extent Information

E5This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Inspection of a site where sterile veterinary medicinal products are manufacturedN.I.

34.  The following fees are payable for the inspection of a site where no immunological veterinary medicinal products are manufactured, but where sterile products are manufactured.

Sites where sterile veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site23,32422,157
Major site13,01012,359
Standard site8,2447,832
Minor site5,0224,770

Extent Information

E14This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Inspection of a site where no immunological or sterile veterinary medicinal products are manufacturedE+W+S

35.  The following fees are payable for the inspection of a site where only non-immunological and non-sterile veterinary medicinal products are manufactured—

[F17Sites where no immunological or sterile veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site21,41622,710
Major site12,85014,144
Standard site8,5669,861
Minor site4,2835,577
If the site is only involved in the manufacture of veterinary medicinal products authorised under Schedule 6 (exemptions for small pet animals)—
Standard site3,2124,507
Minor site2,1423,436]

Extent Information

E6This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Inspection of a site where no immunological or sterile veterinary medicinal products are manufacturedN.I.

35.  The following fees are payable for the inspection of a site where only non-immunological and non-sterile veterinary medicinal products are manufactured—

Site where no immunological or sterile veterinary medicinal products are manufactured
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site14,18013,471
Major site8,3257,909
Standard site6,8546,511
Minor site3,7893,600
If the site is only involved in the manufacture of veterinary medicinal products authorised under Schedule 6 (exemptions for small pet animals—
Standard site5,0554,802
Minor site2,7282,592

Extent Information

E15This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Inspection of a site where veterinary medicinal products are assembledE+W+S

36.  The following fees are payable for the inspection of a site where the only manufacturing process in relation to veterinary medicinal products is their assembly after the product has been put into its immediate container.

[F18Sites where medicinal products are assembled
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site17,13318,427
Major site10,70812,002
Standard site6,4257,719
Minor site4,2835,577]

Extent Information

E7This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Inspection of a site where veterinary medicinal products are assembledN.I.

36.  The following fees are payable for the inspection of a site where the only manufacturing process in relation to veterinary medicinal products is their assembly after the product has been put into its immediate container.

Site where medicinal products are assembled
Type of siteFee (£)
United Kingdom siteSite outside the United Kingdom
Super site11,02510,474
Major site5,9495,652
Standard site4,9174,671
Minor site2,0351,933

Extent Information

E16This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Test sitesE+W+S

37.  The fee for the inspection of a test site is [F19£3,212], or [F20£4,507] for a site outside the United Kingdom.

Extent Information

E8This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Test sitesN.I.

37.  The fee for the inspection of a test site is £3,344, or £3,177 for a site outside the United Kingdom.

Extent Information

E17This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

[F21Animal blood bank or non-food animal stem cell centre authorisationsE+W+S

38.(1) The fee for the inspection of a blood bank is—

(a)£3,212 for a site in the United Kingdom; and

(b)£4,507 for a site outside the United Kingdom.

(2) The fee for the inspection of a non-food animal stem cell centre is—

(a)£2,142 for a site in the United Kingdom; and

(b)£3,436 for a site outside the United Kingdom]

Extent Information

E9This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only

Textual Amendments

Animal blood bank or equine stem cell centre authorisationsN.I.

38.—(1) The fee for an authorisation to operate a blood bank is—

(a)on a first inspection £3,113; and

(b)on each subsequent inspection—

(i)£3,113 for a site in the United Kingdom; and

(ii)£2,966 for a site outside the United Kingdom.

(2) The fee for an authorisation to operate an equine stem cell centre is £3,427, and £3,092 for each subsequent inspection.

(3) The fee for a variation to an authorisation to operate a blood-bank or equine stem cell centre is £320.

Extent Information

E18This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only

Yn ôl i’r brig

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open yr Offeryn Cyfan

Yr Offeryn Cyfan you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Memorandwm Esboniadol

Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel deddfwyd fersiwn a ddefnyddiwyd am y copi print
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Asesiadau Effaith

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

Llinell Amser Newidiadau

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel gwnaed fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill